Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength

Human Immunology

Volumn 73, Issue 7, 2012, Pages 706-710

  Ellis, Thomas M ^a   Schiller, Jennifer J ^a   Roza, Allan M ^b   Cronin, David C ^b   Shames, Brian D ^b,c   Johnson, Christopher P ^b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Hartford Transplant and Surgical Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY;

ARTICLE; B LYMPHOCYTE; BLOOD GROUP TYPING; COMPLEMENT DEPENDENT CYTOTOXICITY; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSORBENT TECHNIQUES; ISOANTIBODIES; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; RISK; SENSITIVITY AND SPECIFICITY;

EID: 84862315473     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.04.007     Document Type: Article

References (18)

1. Zangwill S., Ellis T., Stendahl G., Zahn A., Berger S., Tweddell J. Practical application of the virtual crossmatch. Pediatr Transplant 2007, 11:650.
2. Zangwill S.D., Ellis T.M., Zlotocha J., Jaquiss R.D., Tweddell J.S., Mussatto K.A., et al. The virtual crossmatch - a screening tool for sensitized pediatric heart transplant recipients. Pediatr Transplant 2006, 10:38.
3. Gebel H.M., Bray R.A., Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 2003, 3:1488.
4. Gloor J.M., Winters J.L., Cornell L.D., Fix L.A., Degoey S.R., Knauer R.M., et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010, 10:582.
5. Tambur A.R., Ramon D.S., Kaufman D.B., Friedewald J., Luo X., Ho B., et al. Perception versus reality? Virtual crossmatch - how to overcome some of the technical and logistic limitations. Am J Transplant 2009, 9:1886.
6. Cecka J.M., Kucheryavaya A.Y., Reinsmoen N.L., Leffell M.S. Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches. Am J Transplant 2011, 11:719.
7. El-Awar N., Lee J., Terasaki P.I. HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 2005, 66:989.
8. Lefaucheur C., Loupy A., Hill G.S., Andrade J., Nochy D., Antoine C., et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010, 21:1398.
9. Hahn A, Land G, Strothman R. ASHI laboratory manual; 2000.
10. Empson M.B. Statistics in the pathology laboratory: characteristics of diagnostic tests. Pathology 2001, 33:93.
11. Fawcett T. An introduction to ROC analysis. Pattern Recogn 2006, 27:861.
12. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29.
13. Bray R.A., Gebel H.M. Strategies for human leukocyte antigen antibody detection. Curr Opin Organ Transplant 2009, 14:392.
14. Gebel H.M., Bray R.A. Sensitization and sensitivity: defining the unsensitized patient. Transplantation 2000, 69:1370.
15. Gebel H.M., Bray R.A., Ruth J.A., Zibari G.B., McDonald J.C., Kahan B.D., et al. Flow PRA to detect clinically relevant HLA antibodies. Transplant Proc 2001, 33:477.
16. Johnson C.P., Shames B.D., Brown S., Roza A.M., Cronin D.C.E. T.M. A Single Center Experience. Can a Virtual Crossmatch Replace the Prospective Crossmatch?. Am J Transplant 2009, 9:334.
17. Reinsmoen N.L., Lai C.-H., Vo A., Cao K., Ong G., Naim M., et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation 2008, 86:820.
18. Morris G.P., Phelan D.L., Jendrisak M.D., Mohanakumar T. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation. Hum Immunol 2010, 71:268.